|

BAY 3713372 Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Pipeline

Phase 1/2: 1

Top Sponsors

  • Bayer1

Indications

Birmingham, Alabama1 trial

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.